Rifampicin-induced thrombocytopenia in a patient with abdominal tuberculosis

dc.contributor.authorBoddu, Ren_US
dc.contributor.authorSharma, Aen_US
dc.contributor.authorMishra, Ken_US
dc.contributor.authorKumar, Sen_US
dc.date.accessioned2024-12-07T11:14:11Z
dc.date.available2024-12-07T11:14:11Z
dc.date.issued2024-01
dc.description.abstractMost anti-tubercular drugs are relatively safe, but adverse reactions are not uncommon. Rifampicin is one of the most effective and widely used antituberculosis drugs. Adverse effects due to rifampicin are not uncommon and the patients usually have skin rash, gastrointestinal disturbances, and hepatotoxicity. Rarely, the patients may also have allergic and autoimmune manifestations, which may include life-threatening thrombocytopenia. A high index of suspicion and careful evaluation for temporal association with the suspected drug are required to diagnose drug-induced immune thrombocytopenia. We present a case of rifampicin-induced thrombocytopenia; though relatively rare, it needs attention.en_US
dc.identifier.affiliationsDepartment of Clinical Hematology, Army Hospital (Research and Referralen_US
dc.identifier.affiliationsDepartment of Pathology, Army Hospital (Research and Referral), New Delhi,Indiaen_US
dc.identifier.affiliationsDepartment of Clinical Hematology, Army Hospital (Research and Referral)en_US
dc.identifier.affiliationsDepartment of Clinical Hematology, Army Hospital (Research and Referral)en_US
dc.identifier.citationBoddu R, Sharma A, Mishra K, Kumar S. Rifampicin-induced thrombocytopenia in a patient with abdominal tuberculosis. Annals of the National Academy of Medical Sciences (India). 2024 Jan; 60(1): 26-29en_US
dc.identifier.issn0379-038X
dc.identifier.issn2454-5635
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/241073
dc.languageenen_US
dc.publisherNational Academy of Medical Sciencesen_US
dc.relation.issuenumber1en_US
dc.relation.volume60en_US
dc.source.urihttps://dx.doi.org/10.25259/ANAMS-2022-3-9-(585)en_US
dc.subjectATTen_US
dc.subjectRifampicinen_US
dc.subjectThrombocytopeniaen_US
dc.subjectTuberculosisen_US
dc.titleRifampicin-induced thrombocytopenia in a patient with abdominal tuberculosisen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
anams2024v60n1p26.pdf
Size:
535.39 KB
Format:
Adobe Portable Document Format